Widemann, Brigitte C <br/><br/>
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.  [electronic resource] 

 -  Pediatric blood & cancer  Sep 2014 
 - 1598-602 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.25041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Child<br/>Child, Preschool<br/>Disease Progression<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Neoplasm Staging<br/>Neurofibroma, Plexiform--drug therapy<br/>Neurofibromatosis 1--drug therapy<br/>Prognosis<br/>Pyridones--therapeutic use<br/>Quality of Life<br/>Survival Rate<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult